NCT02003313View on ClinicalTrials.gov

Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,260

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Meningitis
Interventions
BIOLOGICAL

Group T

0.5ml, Intramuscular

BIOLOGICAL

Group C

0.5ml, Intramuscular

Trial Locations (1)

100021

Chaoyang District Centre for Disease Prevention and Control, Beijing

Sponsors
All Listed Sponsors
lead

Beijing Minhai Biotechnology Co., Ltd

INDUSTRY